Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

Malaria continues being a high-impact disease regarding public health worldwide; the WHO report for malaria in 2018 estimated that ~219 million cases occurred in 2017, mostly caused by the parasite Plasmodium falciparum. The disease cost the lives of more than 400,000 people, mainly in Africa. In sp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Lambraño, Jennifer, Curtidor, Hernando, Avendaño, Catalina, Díaz-Arévalo, Diana, Roa, Leonardo, Vanegas, Magnolia, Patarroyo, Manuel E., Patarroyo, Manuel A.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012257/
https://ncbi.nlm.nih.gov/pubmed/32083140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3832513
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars